Oncology Overdrive

In this podcast by Healio, host Shikha Jain, MD, FACP, covers modern day health care in an ever-evolving world. Through interviews with experts, Jain explores hot topics in oncology and beyond.

  1. 1d ago

    Colon cancer screening, prevention through patient advocacy

    In this episode, host Shikha Jain, MD, speaks with Folasade (Fola) May, MD, PhD, about the growing importance of colon cancer screening, and how physicians can use their platform to empower patients against healthcare disparities. ·       How did you end up becoming a public health advocate? 5:55 ·       How can we navigate the rise of misinformation being spread without evidence-based claims? 9:36 ·       Jain and May describe how to educate patients around informed decision-making.  12:59 ·       How are we seeing healthcare disparities evolve, and are we making progress toward improving them? 15:49 ·       Jain and May discuss rising colon cancer in younger populations, and how physicians can advise about prevention. 21:30 ·       How are you addressing healthcare disparities in the current climate? 30:55 We'd love to hear from you! Send your comments/questions to Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Jain on X @ShikhaJainMD and on Instagram @shikhajainmd. May can be reached on Instagram @drfolamay. Jain reports no relevant financial disclosures. May reports being on the scientific advisory board for Abbott Cancer Diagnostics, Geneoscopy and Natera; consulting for Pfizer and Thorne Science; and receiving research funding from the NIH, Veterans Affairs and Stand Up to Cancer.

    Colon cancer screening, prevention through patient advocacy
  2. Jul 23

    Live from ASCO 2026: Disruptive Innovators Awards

    In this episode, recorded live at ASCO Annual Meeting, host Shikha Jain, MD, joins presenters to honor the winners of Healio's 2026 Disruptive Innovators Awards in hematology and oncology. ·       VK Gadi, MD, PhD, presents the Heath Equity Award to Nosayaba Osazuwa-Peters, BDS, PhD, MPH, CHES. 2:13 ·       Hansa Bhargava, MD, presents the Lifetime Disruptor Award to Ann H. Partridge, MD, MPH. 4:33 ·       Hansa Bhargava, MD, presents the Healio NextGen Disruptor Award to Colton Frisco Jones, MD. 7:22 ·       Morgan Collier presents the Woman Disruptor of the Year Award to Erin N. Kobetz, PhD, MPH.  9:43 ·       Richard T. Lee, MD, from City of Hope, accepts the Clinical Innovation Award for the National Clinical Trials System. 11:55 ·       Ryne Wilson, DNP, RN, OCN, presents the Advanced Practice Trailblazer Award to Stacy J. Hines-Dowell, DNP, ACGN, FNP-BC, AGN-BC. 14:43 ·       Diana Gelston presents the Patient Voice Award to Crossroads4Hope and its CEO, Amy Sutton. 16:35 ·       Karine Tawagi, MD, presents the Social Media Influencer Award to Eric K. Singhi, MD. 19:26 ·       Justin McDonnell of Johnson & Johnson accepts the Healio Industry Breakthrough Award for Darzalex Faspro (daratumumab and hyaluronidase-fihj). 21:49 We'd love to hear from you! Send your comments/questions to Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Jain on X: @ShikhaJainMD and on Instagram @shikhajainmd. To learn more about Healio Disruptive Innovators, visit Healio.com/Innovators. Jain reports no relevant financial disclosures.

    Live from ASCO 2026: Disruptive Innovators Awards
  3. Jun 25

    Breakthroughs in pancreatic cancer research, treatment spark excitement at ASCO

    In this episode, Shikha Jain, MD, speaks with Revolution Medicines' Alan Sandler, MD, about groundbreaking advancements with daraxonrasib and how these findings will continue to impact metastatic pancreatic cancer. Daraxonrasib (RMC-6236, Revolution Medicines) is an investigational, oral pan-RAS inhibitor in development for treatment of advanced solid tumors, including pancreatic ductal adenocarcinoma. ·       Why the RASolute 302 trial got a standing ovation at ASCO. 3:16 ·       What do you think changed scientifically to make this particular drug and its results possible? 6:12 ·       What does the multi-selective RAS inhibition of this drug mean, and how does it differ from other drugs? 10:23 ·       How would you recommend navigating the early access program (EAP) for patients and physicians who want this drug now? 13:13 ·       What excites you about the future of pancreatic cancer and RAS treatment? 14:18 ·       How can you imagine when these drugs will get into the hands of patients if we see good results? 17:28 We'd love to hear from you! Send your comments/questions to Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Jain on X: @ShikhaJainMD and on Instagram @shikhajainmd. Sandler can be reached via email at inquiries@revmed.com. Reference: ·        Wolpin BM, et al. LBA5. Presented at: ASCO Annual Meeting; May 29-June 2, 2026; Chicago. Jain and Sandler report no relevant financial disclosures.

    Breakthroughs in pancreatic cancer research, treatment spark excitement at ASCO
  4. May 14

    The future of oncology nursing, multidisciplinary care

    In this episode, host Shikha Jain, MD, speaks with Jessica MacIntyre, DNP, about her role and goals as president of the Oncology Nursing Society, multidisciplinary focuses within cancer care and more. ·       Welcome to another exciting episode of Oncology Overdrive 1:22 ·       About Jessica MacIntyre, DNP, MBA, APRN, AOCNP, FAANP 1:34 ·       The interview 2:50 ·       Tell me about how you got to where you are today […] What was your journey to becoming a nurse practitioner, and into the leadership role you hold today? 3:15 ·       What is Oncology Nursing Society (ONS)? What does it do, and how did you become president?  5:17 ·       What are your goals as president of ONS? 9:08 ·       Jain and MacIntyre on the importance of multidisciplinary approaches to cancer care. 12:28 ·       What excites you about the role of nurses and nurse practitioners, and the future of the oncology team as a whole? 14:34 ·       Where do you see the future of patient navigation going? […] Where do you see AI playing a role in all of this? 17:42 ·       What do you say to people who are scared of AI becoming all-encompassing? 20:41 ·       Jain and MacIntyre on embracing and improving the use of AI in cancer care. 22:14 ·       What do you recommend to nurses as they embark on their careers? […] How can we make sure nurses are working to the top of their license while supporting the cancer care team? 24:09 ·       Jain and MacIntyre on the increasing importance of advocacy in health care. 26:55 ·       If someone could only listen to the last minute of this episode, what would you want listeners to take away? 28:31 ·       How to contact MacIntyre 30:00 ·       Thanks for listening 30:56 Jessica MacIntyre, DNP, MBA, APRN, AOCNP, FAANP, is president of the Oncology Nursing Society and executive director of clinical operations at Sylvester Comprehensive Cancer Center, part of University of Miami Miller School of Medicine. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. MacIntyre can be reached on LinkedIn, or via email jmacintyre@med.miami.edu. Jain reports no relevant financial disclosures. MacIntyre reports compensation from Johnson & Johnson for participation on a nursing panel.

    The future of oncology nursing, multidisciplinary care
  5. Apr 9

    Balancing humor, hope in medicine with Dr. & Lady Glaucomflecken

    In this episode, host Shikha Jain, MD, speaks with Will and Kristin Flanary, also known as Dr. and Lady Glaucomflecken, about using humor and content creation to tackle complex issues, their personal experiences navigating the health care system and more. ·       Welcome to another exciting episode of Oncology Overdrive 0:14 ·       About the Glaucomfleckens 0:27 ·       The interview 1:11 ·       Can you tell us the story behind how the Glaucomfleckens came to be, and how you got into the content creation space? 1:49 ·       How did you go from writing your blog to having an international platform for storytelling?  4:02 ·       Why do you think your humor allows difficult or frustrating conversations for physicians to be addressed? 8:21 ·       Did your colleagues know about your growing platform when you were first making videos? Now, do they bring it up to you? 10:03 ·       What do you say to people who think doctors should not be political? 12:21 ·       How do we help physicians and medical students put out good content, and how can we help patients determine who to listen to? 17:33 ·       Discussion on developing guidelines with social media posting. 21:25 ·       How have your major health events and experiences shaped you as a unit, and how has it influenced how you talk about medicine? 24:16 ·       Kristin, how has it been for you to talk about these experiences to advocate for fellow co-survivors? 27:06 ·       What are the biggest challenges that we need to face within the health care system right now? 30:49 ·       Discussion on Dr. and Lady Glaucomflecken's favorite, most accurate and most surprisingly resonant characters 36:37 ·       What gives you hope? 40:45 ·       If someone could only listen to the last minute of this episode, what would you want listeners to take away? 42:24 ·       How to contact the Glaucomfleckens 43:04 ·       Thanks for listening 44:02 Will Flanary, MD, and Kristin Flanary bring humor and humanity to the health care industry. Dr. Flanary, better known as "Dr. Glaucomflecken," creates medical-themed comedy shorts on social media for an audience of over 5 million. Kristin, also known as "Lady Glaucomflecken," advocates for patients and "co-survivors" of serious illness. Together, the couple cohosts the medical comedy podcast, "Knock, Knock, Hi! with the Glaucomfleckens," and uses their multimedia keynote speaking, writing and social media presence to transform their dramatic personal health history into an opportunity for laughter, education and advocacy. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. The Glaucomfleckens can be reached at https://glaucomflecken.com/. Jain and the Flanarys report no relevant financial disclosures.

    Balancing humor, hope in medicine with Dr. & Lady Glaucomflecken
  6. Mar 12

    Openness to Innovation with Don Dizon, MD (Re-Release)

    In this throwback episode, host Shikha Jain, MD, speaks with Don Dizon, MD, about innovation throughout times of uncertainty in medicine, challenges currently facing physicians and more. ·       Welcome to another exciting episode of Oncology Overdrive 0:15 ·       About Dizon 0:25 ·       The interview 1:08 ·       How did you decide to become an oncologist and navigate a traditional academic career with many non-traditional "add-ons"? 1:46 ·       Jain and Dizon on the importance of providing humanity to physicians. 5:40 ·       Jain and Dizon on finding balance when providing patients with information.  7:45 ·       Jain and Dizon on federal funding challenges facing oncology advancements.  8:39 ·       Can you tell us more about transitioning to your new role at Tufts? 11:43 ·       Jain and Dizon on the growing amount of career shifts in medicine. 15:35 ·       How do we move forward with these new guardrails up from corporatization? 17:15 ·       Jain and Dizon on how the age of social media has changed the perception, training and demands of doctors. 22:39 ·       Dizon and Jain on the power of being able to admit "I don't know." 25:52 ·       What are some tips that you have for new attendings and people just starting in their careers? 31:13 ·       Dizon and Jain on the importance of humanizing patients during their care. 38:15 ·       If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 41:52 ·       How to contact Dizon 42:32 ·       Thanks for listening 43:26 Don Dizon, MD, is a professor of medicine at Tufts University and is the system chief of hematology and oncology for Tufts Medicine. He is also the editor in chief of CA: A Cancer Journal for Clinicians, the flagship journal of the American Cancer Society as well as the vice-chair of membership and accrual at the SWOG Cancer Research Network. We'd love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Dizon can be reached on Tiktok @drdonsdizon, Instagram @drdonsdizon and LinkedIn. Disclosures: Jain and Dizon report no relevant financial disclosures.

    Openness to Innovation with Don Dizon, MD (Re-Release)
4.9
out of 5
15 Ratings

About

In this podcast by Healio, host Shikha Jain, MD, FACP, covers modern day health care in an ever-evolving world. Through interviews with experts, Jain explores hot topics in oncology and beyond.

More From Healio

You Might Also Like